Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64901 - 64925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	CERS2	29956	upregulated	resveratrol results in increased expression of CERS2 mRNA	1q21.3	A23906
Resveratrol	Investigational	CERS4	79603	upregulated	resveratrol results in increased expression of CERS4 mRNA	19p13.2	A23906
Resveratrol	Investigational	CERS6	253782	upregulated	resveratrol results in increased expression of CERS6 mRNA	2q24.3	A23906
Resveratrol	Investigational	CGB3	1082	upregulated	resveratrol results in increased expression of CGB3 mRNA	19q13.33	A23859
Resveratrol	Investigational	CHEK1	1111	downregulated	resveratrol results in decreased expression of CHEK1 mRNA	11q24.2	A23858
Resveratrol	Investigational	CHEK1	1111	upregulated	resveratrol results in increased expression of CHEK1 mRNA	11q24.2	A21103
Resveratrol	Investigational	CHGB	1114	upregulated	resveratrol results in increased expression of CHGB mRNA	20p12.3	A23852
Resveratrol	Investigational	CHI3L1	1116	downregulated	resveratrol results in decreased expression of CHI3L1 mRNA	1q32.1	A23907
Resveratrol	Investigational	CHRNA4	1137	upregulated	resveratrol results in increased expression of CHRNA4 mRNA	20q13.33	A23847
Resveratrol	Investigational	CKS2	1164	downregulated	resveratrol results in decreased expression of CKS2 mRNA	9q22.2	A23857
Resveratrol	Investigational	CLCF1	23529	downregulated	resveratrol results in decreased expression of CLCF1 mRNA	11q13.2	A23893
Resveratrol	Investigational	CLDN1	9076	downregulated	resveratrol results in decreased expression of CLDN1 mRNA	3q28	A21103
Resveratrol	Investigational	CLDN1	9076	upregulated	resveratrol results in increased expression of CLDN1 mRNA	3q28	A23908
Resveratrol	Investigational	CLU	1191	upregulated	resveratrol results in increased expression of CLU mRNA	8p21.1	A23909
Resveratrol	Investigational	CNBP	7555	upregulated	resveratrol results in increased expression of CNBP mRNA	3q21.3	A20482
Resveratrol	Investigational	COL18A1	80781	downregulated	resveratrol results in decreased expression of COL18A1 mRNA	21q22.3	A23893
Resveratrol	Investigational	COL1A1	1277	downregulated	resveratrol results in decreased expression of COL1A1 mRNA	17q21.33	A23849 A23910 A23851
Resveratrol	Investigational	COL1A1	1277	upregulated	resveratrol results in increased expression of COL1A1 mRNA	17q21.33	A21103
Resveratrol	Investigational	COL3A1	1281	downregulated	resveratrol results in decreased expression of COL3A1 mRNA	2q32.2	A23910
Resveratrol	Investigational	COL5A1	1289	downregulated	resveratrol results in decreased expression of COL5A1 mRNA	9q34.3	A21103
Resveratrol	Investigational	COPS3	8533	upregulated	resveratrol results in increased expression of COPS3 mRNA	17p11.2	A22498
Resveratrol	Investigational	CORO1C	23603	upregulated	resveratrol results in increased expression of CORO1C mRNA	12q24.11	A22289
Resveratrol	Investigational	CPT1A	1374	upregulated	resveratrol results in increased expression of CPT1A mRNA	11q13.3	A23911
Resveratrol	Investigational	CRABP2	1382	upregulated	resveratrol results in increased expression of CRABP2 mRNA	1q23.1	A22498 A23859
Resveratrol	Investigational	CREBBP	1387	upregulated	resveratrol results in increased expression of CREBBP mRNA	16p13.3	A23885

Displaying entries 64901 - 64925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability